nebacumab

nebacumab Struktur
138330-99-1
CAS-Nr.
138330-99-1
Englisch Name:
nebacumab
Synonyma:
Ha-1a;Centoxin;Septomonab;Ha-1A monoclonal antibody
CBNumber:
CB31368007
Summenformel:
Molgewicht:
0
MOL-Datei:
Mol file

nebacumab Eigenschaften

Sicherheit

nebacumab Chemische Eigenschaften,Einsatz,Produktion Methoden

Beschreibung

Centoxin is an anti-endotoxin human monoclonal antibody indicated for the treatment of Gram-negative sepsis and septic shock.The drug was reported to resolve organ failure within one week of treatment. The results also suggest that centoxin blocks the release of tumor necrosis factor in septic patients. It is also under investigation for the treatment of bum patients and meningococcal septicemia.

Originator

Centocor (U.S.A.)

Trademarks

HA-1A

nebacumab Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


nebacumab Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 0)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Copyright 2019 © ChemicalBook. All rights reserved